Pre-Market Most Active for Aug 1, 2013 : DELL, JCP, BAC, SUNE, FB, ALU, SXC, BCRX, XOM, ARNA, MYL, HALO

By
A A A

The NASDAQ 100 Pre-Market Indicator is up 13.3 to 3,103.49. The total Pre-Market volume is currently 18,252,633 shares traded.

The following are the most active stocks for the pre-market session :

Dell Inc. ( DELL ) is +0.24 at $12.90, with 1,883,510 shares traded. DELL's current last sale is 94.51% of the target price of $13.65.

J.C. Penney Company, Inc. Holding Company ( JCP ) is +1 at $15.60, with 1,449,032 shares traded. As reported in the last short interest update the days to cover for JCP is 9.053986; this calculation is based on the average trading volume of the stock.

Bank of America Corporation ( BAC ) is +0.18 at $14.78, with 984,321 shares traded. Over the last four weeks they have had 7 up revisions for the earnings forecast, for the fiscal quarter ending Dec 2013. The consensus EPS forecast is $0.29. BAC's current last sale is 105.57% of the target price of $14.

SunEdison, Inc. ( SUNE ) is unchanged at $10.08, with 576,000 shares traded.SUNE is scheduled to provide an earnings report on 8/7/2013, for the fiscal quarter ending Jun2013. The consensus earnings per share forecast is -0.16 per share, which represents a 14 percent increase over the EPS one Year Ago

Facebook, Inc. ( FB ) is +0.36 at $37.16, with 476,541 shares traded. Over the last four weeks they have had 10 up revisions for the earnings forecast, for the fiscal quarter ending Sep 2013. The consensus EPS forecast is $0.13. As reported by Zacks, the current mean recommendation for FB is in the "buy range".

Alcatel Lucent ( ALU ) is -0.03 at $2.51, with 469,750 shares traded., following a 52-week high recorded in prior regular session.

SunCoke Energy, Inc. ( SXC ) is unchanged at $15.80, with 450,000 shares traded. SXC's current last sale is 87.78% of the target price of $18.

BioCryst Pharmaceuticals, Inc. ( BCRX ) is +0.7 at $5.10, with 273,079 shares traded. RTT News Reports: BioCryst Pharma To Begin Phase 2a Trial Of Oral Kallikrein Inhibitor BCX4161

Exxon Mobil Corporation ( XOM ) is -1.57 at $92.18, with 261,698 shares traded. Over the last four weeks they have had 5 up revisions for the earnings forecast, for the fiscal quarter ending Jun 2013. The consensus EPS forecast is $1.89. RTT News Reports: Exxon Mobil Q2 Profit Slumps - Quick Facts

Arena Pharmaceuticals, Inc. ( ARNA ) is +0.18 at $7.13, with 205,435 shares traded. RTT News Reports: Arena Pharma To Present At The 2013 Wells Fargo Conference; Webcast At 2:25 PM

Mylan Inc. ( MYL ) is +0.34 at $33.90, with 203,250 shares traded. RTT News Reports: Mylan Q2 Profit Beats View; Backs FY13 Adj. EPS View - Quick Facts

Halozyme Therapeutics, Inc. ( HALO ) is -1.62 at $6.89, with 191,622 shares traded.HALO is scheduled to provide an earnings report on 8/5/2013, for the fiscal quarter ending Jun2013. The consensus earnings per share forecast is -0.14 per share, which represents a -13 percent increase over the EPS one Year Ago



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: News Headlines , Pre-market Most Active


NASDAQ.com News

NASDAQ.com News

More from NASDAQ.com News:

Related Videos

Stocks

Referenced

Most Active by Volume

106,679,460
  • $17.03 ▲ 0.47%
101,357,777
  • $38.65 ▼ 5.57%
61,830,117
  • $89.89 ▼ 4.26%
54,116,071
  • $5.11 ▼ 4.49%
50,121,934
  • $101.06 ▲ 0.10%
49,993,927
  • $3.52 ▼ 1.40%
47,717,687
  • $11.44 ▼ 4.67%
44,793,169
  • $99.05 ▼ 0.93%
As of 9/22/2014, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com